Epidemiology, Comparative Effectiveness Research, and the National Institutes of Health: Forces for Health

Overview

Journal Epidemiology

Specialty Public Health

Date 2011 Aug 4

PMID 21811109

Citations 1

Authors

Michael S Lauer

Richard Hodes

Affiliations

Soon will be listed here.

Citing Articles

Cardiovascular epidemiology in a changing world--challenges to investigators and the National Heart, Lung, and Blood Institute.

Sorlie P, Bild D, Lauer M Am J Epidemiol. 2012; 175(7):597-601.

PMID: 22415032 PMC: 3390031. DOI: 10.1093/aje/kws138.

References

Go A, Magid D, Wells B, Sung S, Cassidy-Bushrow A, Greenlee R . The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2009; 1(2):138-47. DOI: 10.1161/CIRCOUTCOMES.108.801654. View

Garber A . A menu without prices. Ann Intern Med. 2008; 148(12):964-6. DOI: 10.7326/0003-4819-148-12-200806170-00223. View

Curtis J, Luebbert J, Wang Y, Rathore S, Chen J, Heidenreich P . Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009; 301(16):1661-70. PMC: 2805129. DOI: 10.1001/jama.2009.547. View

Ginsberg H, Elam M, Lovato L, Crouse 3rd J, Leiter L, Linz P . Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010; 362(17):1563-74. PMC: 2879499. DOI: 10.1056/NEJMoa1001282. View

Pocock S, Elbourne D . Randomized trials or observational tribulations?. N Engl J Med. 2000; 342(25):1907-9. DOI: 10.1056/NEJM200006223422511. View

Lauer M . The historical and moral imperatives of comparative effectiveness research. Stat Med. 2010; 29(19):1982-4. DOI: 10.1002/sim.3927. View

. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265(24):3255-64. View

. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288(23):2981-97. DOI: 10.1001/jama.288.23.2981. View

BIGGER Jr J, Fleiss J, KLEIGER R, Miller J, Rolnitzky L . The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984; 69(2):250-8. DOI: 10.1161/01.cir.69.2.250. View

10.

Ashton H, Buxton M, Day N, Kim L, Marteau T, Scott R . The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002; 360(9345):1531-9. DOI: 10.1016/s0140-6736(02)11522-4. View

11.

Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View

12.

Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18):1343-50. DOI: 10.1056/NEJM200105033441801. View

13.

Althabe F, Buekens P, Bergel E, Belizan J, Campbell M, Moss N . A behavioral intervention to improve obstetrical care. N Engl J Med. 2008; 358(18):1929-40. DOI: 10.1056/NEJMsa071456. View

14.

Clancy C, Collins F . Patient-Centered Outcomes Research Institute: the intersection of science and health care. Sci Transl Med. 2010; 2(37):37cm18. DOI: 10.1126/scitranslmed.3001235. View

15.

Kannel W, DAWBER T, Kagan A, REVOTSKIE N, Stokes 3rd J . Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med. 1961; 55:33-50. DOI: 10.7326/0003-4819-55-1-33. View

16.

. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984; 251(3):351-64. DOI: 10.1001/jama.1984.03340270029025. View

17.

Buchwald H, VARCO R, Matts J, Long J, Fitch L, Campbell G . Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990; 323(14):946-55. DOI: 10.1056/NEJM199010043231404. View

18.

Lauer M, Collins F . Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. JAMA. 2010; 303(21):2182-3. DOI: 10.1001/jama.2010.726. View

19.

Ryan J, Peterson E, Chen A, Roe M, Ohman E, Cannon C . Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines).... Circulation. 2005; 112(20):3049-57. DOI: 10.1161/CIRCULATIONAHA.105.582346. View

20.

Pell J, Haw S, Cobbe S, Newby D, Pell A, Fischbacher C . Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008; 359(5):482-91. DOI: 10.1056/NEJMsa0706740. View